Defining Retinal and Choroidal Structures Using Hyperspectral Imaging
NCT: NCT07530783 · TERMINATED
Brief Summary
This study investigates a novel, non-invasive imaging technique called hyperspectral retinal imaging to improve the identification and characterisation of retinal and choroidal structures in both healthy and diseased eyes. Hyperspectral imaging captures retinal images across multiple wavelengths of light, generating detailed spectral information that may reveal biological and structural features not visible with conventional retinal photography. Approximately 1000 participants will undergo retinal imaging at specialist eye clinics in Melbourne, Australia. The study aims to determine whether hyperspectral imaging can detect spectral signatures associated with retinal and optic nerve diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration, and whether these signatures correlate with disease severity.
Frequently Asked Questions
What is Defining Retinal and Choroidal Structures Using Hyperspectral Imaging?
Defining Retinal and Choroidal Structures Using Hyperspectral Imaging is a clinical trial registered under NCT07530783. Current status: TERMINATED.
What is the status of NCT07530783?
The current status of NCT07530783 (Defining Retinal and Choroidal Structures Using Hyperspectral Imaging) is: TERMINATED.
When did Defining Retinal and Choroidal Structures Using Hyperspectral Imaging start?
Defining Retinal and Choroidal Structures Using Hyperspectral Imaging started on 2016-02-25.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.